Log In
Print
BCIQ
Print
Print this Print this
 

dulaglutide (GLP-1Fc, Trulicity) (LY2189265)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionLong-acting glucagon-like peptide-1 (GLP-1) receptor agonist
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of ActionGlucagon-like peptide-1 (GLP-1) receptor agonist
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today